Item
VITAMIN B6 (PYRIDOXINE) HCL (8200)
Pyridoxine Hydrochloride -100%
Nutrient / Vitamin
Attributes
- Gluten-free
- Halal
- Ingredient declaration
- Kosher
- PHO-free
- Ready-to-Eat (RTE)
- Vegan
- Non-GMO
Locations
| Location name | Address |
|---|---|
| Jiangxi Tianxin Pharmaceutical Co., Ltd. | Leping Industrial Zone, Leping City Jingdezhen City, JX 333300 CHN |
| Prinova USA | 6525 Muirfield Drive. Hanover Park, IL 60133 |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| HACCP | Jiangxi Tianxin Pharmaceutical Co., Ltd. | 3rd party-Haccp doc - Prinova.pdf | 5/18/2022 | 5/17/2025 |
| Gluten | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Allergen - 2023-10-12T134757.488.pdf | 10/11/2023 | 10/10/2024 |
| Allergens EU/UK | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Allergens EU/UK.pdf | 1/27/2025 | 1/27/2027 |
| Allergens | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Allergens.pdf | 5/4/2023 | 5/3/2025 |
| CoA Sample | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Approved COA Template - 2025-02-24T121056.024.pdf | 2/24/2025 | 2/24/2027 |
| WADA/NSF/NFL Statement | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Banned Substance (35).pdf | 10/11/2022 | 10/10/2025 |
| Melamine | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Contaminants and Impurities - 2023-10-25T152314.049.pdf | 10/11/2023 | 10/10/2024 |
| Residual Statement | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Contaminants and Impurities - 2023-11-20T132837.103.pdf | 10/11/2023 | 10/10/2024 |
| Heavy Metal | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Contaminants and Impurities - 2025-02-26T153155.298.pdf | 2/26/2025 | 2/26/2027 |
| Pesticide | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Contaminants and Impurities (95).pdf | 10/11/2022 | 10/10/2024 |
| Country of Origin EU/UK | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Country of Origin EU/UK.pdf | 10/26/2022 | 10/25/2025 |
| Country of Origin | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Country of Origin.pdf | 7/10/2024 | 7/10/2027 |
| HACCP Process Flow Diagram | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Flow Chart - 2025-01-10T172322.251.pdf | 10/11/2023 | 10/10/2025 |
| FSVP Assessment Form | Jiangxi Tianxin Pharmaceutical Co., Ltd. | FSVP Assessment Form.pdf | 2/26/2025 | 2/26/2026 |
| GMO | Jiangxi Tianxin Pharmaceutical Co., Ltd. | GMO - 2024-09-11T155532.580.pdf | 10/11/2023 | 10/10/2025 |
| Halal | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Halal Certificate (64).pdf | 12/15/2021 | 12/14/2025 |
| Item Questionnaire | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Item Questionnaire.pdf | 2/14/2025 | 2/14/2028 |
| Kosher | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Kosher Certificate - 2024-07-29T133550.312.pdf | 6/18/2024 | 6/30/2025 |
| National Bioengineered Food Disclosure Standard (Simplified) | Jiangxi Tianxin Pharmaceutical Co., Ltd. | National Bioengineered Food Disclosure Standard (Simplified).pdf | 9/25/2023 | 9/24/2026 |
| Nutrition EU/UK | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Nutrition EU/UK.pdf | 1/31/2024 | 1/30/2027 |
| Nutrition | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Nutrition.pdf | 7/22/2024 | 7/22/2027 |
| Natural | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Organic Compliance - 2023-11-20T134126.137.pdf | 2/4/2023 | 2/4/2024 |
| Sewage Statement | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Organic Compliance (96).pdf | 2/4/2023 | 2/3/2025 |
| Food Contact Packaging Certificate of Compliance | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Packaging Declaration - 2023-09-21T102946.696.pdf | 10/11/2022 | 10/10/2025 |
| Label Sample | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Packaging Declaration - 2025-01-10T172947.774.pdf | 10/11/2024 | 10/11/2025 |
| Lot Code | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Packaging Declaration (88).pdf | 10/11/2022 | 10/10/2025 |
| Ingredient Statement | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Product Data Sheet - 2024-11-22T154948.121.pdf | 10/3/2022 | 10/2/2025 |
| EtO Statement | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Production Process (33).pdf | 10/11/2022 | 10/10/2025 |
| Irradiation Status Statement | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Production Process (33).pdf | 10/11/2022 | 10/10/2024 |
| California Prop. 65 | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Prop 65 - 2024-10-02T143413.887.pdf | 6/27/2024 | 6/27/2026 |
| BSE - TSE | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Regulatory Information Sheet - 2023-04-03T104629.933.pdf | 10/11/2022 | 10/10/2025 |
| Vegan/Vegetarian Statement | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Regulatory Information Sheet - 2023-06-09T163349.942.pdf | 10/11/2022 | 10/10/2024 |
| No Animal Ingredient Statement | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Regulatory Information Sheet - 2023-11-20T132326.704.pdf | 10/11/2023 | 10/10/2024 |
| Animal Testing Statement | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Regulatory Information Sheet - 2025-01-13T114936.021.pdf | 10/11/2023 | 10/10/2025 |
| Organic | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Regulatory Information Sheet (99).pdf | 10/11/2022 | 10/11/2025 |
| Safety Data Sheet (SDS) | Jiangxi Tianxin Pharmaceutical Co., Ltd. | SDS - 2024-09-27T113341.730.pdf | 10/18/2023 | 10/17/2026 |
| Product Specification Sheet | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Specification - Factory - 2025-02-14T135039.550.pdf | 12/17/2024 | 12/17/2027 |
| Shelf Life | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Specification - Factory (55).pdf | 10/11/2022 | 10/10/2024 |
| Suitability Requirements | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Suitability Requirements.pdf | 2/1/2023 | 1/31/2026 |
| GRAS/NDI/ODI Statement | Jiangxi Tianxin Pharmaceutical Co., Ltd. | US Regulatory Status (2).pdf | 7/9/2024 | 7/9/2027 |
